| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.098 | 0.07 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |